Aprogen Biologics Inc. (KRX: 003060)

Market Cap	132.57B
Revenue (ttm)	68.03B
Net Income (ttm)	-141.77B
Shares Out	197.57M
EPS (ttm)	-1,529.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	358,501
Open	709.00
Previous Close	735.00
Day's Range	703.00 - 725.00
52-Week Range	611.00 - 3,080.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-vira...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 377
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003060